These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3274828

  • 1. Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13.
    Kirkman RL, Barrett LV, Koltun WA, Diamantstein T.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):618-9. PubMed ID: 3274828
    [No Abstract] [Full Text] [Related]

  • 2. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K, Kupiec-Weglinski JW, Hancock WW, Stunkel K, Diamantstein T, Tilney NL.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):281-2. PubMed ID: 1990532
    [No Abstract] [Full Text] [Related]

  • 3. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.
    Lowry RP, Konieczny B, Alexander D, Larsen C, Pearson T, Smith S, Narula S.
    Transplant Proc; 1995 Feb; 27(1):392-4. PubMed ID: 7879034
    [No Abstract] [Full Text] [Related]

  • 4. Prolongation of fetal pancreas allograft survival in mice treated with anti-IL-2 receptor monoclonal antibody (PC61) conjugated with idarubicin.
    Koulmanda M, Pietersz G, McKenzie IF, Mandel TE.
    Transplant Proc; 1990 Oct; 22(5):2113-4. PubMed ID: 2219312
    [No Abstract] [Full Text] [Related]

  • 5. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M, Suzuki J, Yagita H, Okumura K, Sekiguchi M.
    Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
    [No Abstract] [Full Text] [Related]

  • 6. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
    Tinubu SA, Hakimi J, Kondas JA, Bailon P, Familletti PC, Spence C, Crittenden MD, Parenteau GL, Dirbas FM, Tsudo M.
    J Immunol; 1994 Nov 01; 153(9):4330-8. PubMed ID: 7930631
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of induction of transplantation tolerance using donor antigen and anti-CD4 monoclonal antibody.
    Wood KJ, Bushell AR, Darby CR, Pearson TC, West L, Morris PJ.
    Transplant Proc; 1991 Feb 01; 23(1 Pt 1):133-4. PubMed ID: 1990498
    [No Abstract] [Full Text] [Related]

  • 8. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection.
    Pelletier R, Ohye R, Kincade P, Ferguson R, Orosz C.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):839-41. PubMed ID: 7679845
    [No Abstract] [Full Text] [Related]

  • 9. Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
    Kupiec-Weglinski JW, Padberg W, Uhteg LC, Towpik E, Lord RH, Ma L, Diamantstein T, Strom TB, Tilney NL.
    Transplant Proc; 1987 Feb 01; 19(1 Pt 1):591-3. PubMed ID: 2978926
    [No Abstract] [Full Text] [Related]

  • 10. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
    Orosz CG, Bergese SD, Huang EH, Vanbuskirk AM.
    Transplant Proc; 1995 Feb 01; 27(1):387-8. PubMed ID: 7533414
    [No Abstract] [Full Text] [Related]

  • 11. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
    Lord RH, Hancock WW, Colby AJ, Padberg W, Diamantstein T, Kupiec-Weglinski JW, Tilney NL.
    Transplant Proc; 1987 Feb 01; 19(1 Pt 1):354-5. PubMed ID: 3079156
    [No Abstract] [Full Text] [Related]

  • 12. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC, Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of murine cardiac allograft by monoclonal antibodies to IL-2 receptor alpha chain and beta chain.
    Isobe M, Suzuki J, Okubo Y, Horie S, Tanaka T, Miyasaka M, Sekiguchi M.
    Transplant Proc; 1997 Jun 01; 29(4):2301-2. PubMed ID: 9193630
    [No Abstract] [Full Text] [Related]

  • 14. Insights into the mechanism of allograft acceptance in T-cell receptor (beta-chain) transgenic mice.
    Barrett LV, Rimm IJ, Wiens GR, Seidman JG, Kirkman RL.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):366-7. PubMed ID: 8438338
    [No Abstract] [Full Text] [Related]

  • 15. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M, Jendrisak G, Gamero J, Mohanakumar T.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM.
    J Heart Lung Transplant; 1997 Sep 01; 16(9):889-904. PubMed ID: 9322138
    [Abstract] [Full Text] [Related]

  • 17. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z, Cobbold S, Waldmann H, Metcalfe S.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract] [Full Text] [Related]

  • 18. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M, Ihara A.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract] [Full Text] [Related]

  • 19. Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts.
    Kupiec-Weglinski JW, Sablinski T, Hancock WW, Mix CT, Tilney NL.
    Transplant Proc; 1991 Feb 01; 23(1 Pt 1):285-6. PubMed ID: 1990533
    [No Abstract] [Full Text] [Related]

  • 20. A rat anti-mouse CD3 monoclonal antibody induces long-term skin allograft survival without inducing side effects.
    Vossen AC, Tibbe GJ, van Oudenaren A, Vredendaal AE, Benner R, Savelkoul HF.
    Transplant Proc; 1994 Dec 01; 26(6):3157-8. PubMed ID: 7998101
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.